Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6766)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2013 (publication date) through Nov 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He Q, Lu WS, Liu Y, Guan YS, Kuang AR. 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma. World J Gastroenterol 2013; 19(47): 9104-9110 [PMID: 24379637 DOI: 10.3748/wjg.v19.i47.9104] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i47/9104.htm |
| Number | Citing Articles |
| 1 |
Jia-Yan Ni, Lin-Feng Xu, Wei-Dong Wang, Hong-Liang Sun, Yao-Ting Chen. Conventional transarterial chemoembolization <italic>vs</italic> microsphere embolization in hepatocellular carcinoma: A meta-analysis. World Journal of Gastroenterology 2014; 20(45): 17206-17217 doi: 10.3748/wjg.v20.i45.17206
|
| 2 |
Cory D. Bovenzi, James Hamilton, Patrick Tassone, Jennifer Johnson, David M. Cognetti, Adam Luginbuhl, William M. Keane, Tingting Zhan, Madalina Tuluc, Voichita Bar-Ad, Ubaldo Martinez-Outschoorn, Joseph M. Curry. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/242437
|
| 3 |
Ruiqi Liu, Hong Li, Yihua Qiu, Hongguang Liu, Zhen Cheng. Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides. Pharmaceuticals 2022; 15(11): 1339 doi: 10.3390/ph15111339
|
| 4 |
Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics. Immunology 2024; 171(4): 464 doi: 10.1111/imm.13743
|
| 5 |
Jun Li, Jingliang Xing, Yefa Yang, Jingfeng Liu, Wentao Wang, Yong Xia, Zhenlin Yan, Kui Wang, Dong Wu, Lu Wu, Xuying Wan, Tian Yang, Chunfang Gao, Anfeng Si, Hongyang Wang, Mengchao Wu, Wan Yee Lau, Zhinan Chen, Feng Shen. Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial. The Lancet Gastroenterology & Hepatology 2020; 5(6): 548 doi: 10.1016/S2468-1253(19)30422-4
|
| 6 |
Chai-Hong Yeong, Mu-hua Cheng, Kwan-Hoong Ng. Therapeutic radionuclides in nuclear medicine: current and future prospects. Journal of Zhejiang University SCIENCE B 2014; 15(10): 845 doi: 10.1631/jzus.B1400131
|
| 7 |
Yongbing Sun, Wen Ma, Yuanyuan Yang, Mengxue He, Aimin Li, Lei Bai, Bin Yu, Zhiqiang Yu. Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy. Asian Journal of Pharmaceutical Sciences 2019; 14(6): 581 doi: 10.1016/j.ajps.2019.04.005
|
| 8 |
Hui Chen, Gang Nan, Ding Wei, Ren-You Zhai, Ming Huang, Wu-Wei Yang, Bao-Cai Xing, Xu Zhu, Hai-Feng Xu, Xiao-Dong Wang, Xiao-Yong Zhang, Bao-Rang Zhu, Peng Liu, Guang Cao, Song Gao, Chun-Yi Hao, Ren-Jie Yang, Jian-Hai Guo, Xin Zhang, Kun Gao, Kun Wang, Jian-Feng Wang, Zi-Yu Li, Lin-Zhong Zhu, Rong Ding, Jing Li, Ling Zhao, Yu-Jun Shao, Hai-Chun Liu, Jie-Lai Xia, Ling Wang, Ling-Min Kong, Zhi-Nan Chen, Huijie Bian. Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial. Journal of Nuclear Medicine 2022; 63(4): 556 doi: 10.2967/jnumed.121.262136
|
| 9 |
Jeong-Hun Kang, Riki Toita, Masaharu Murata. Liver cell-targeted delivery of therapeutic molecules. Critical Reviews in Biotechnology 2016; 36(1): 132 doi: 10.3109/07388551.2014.930017
|
| 10 |
Ze-xin Zhu, Ming-heng Liao, Xiao-xue Wang, Ji-wei Huang. Transcatheter Arterial Chemoembolization Plus131I-Labelled Metuximab versus Transcatheter Arterial Chemoembolization Alone in Intermediate/Advanced Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Korean Journal of Radiology 2016; 17(6): 882 doi: 10.3348/kjr.2016.17.6.882
|
| 11 |
Hu Chen, Minglei Teng, Hongrui Zhang, Xiaoliu Liang, Hongwei Cheng, Gang Liu. Advanced radionuclides in diagnosis and therapy for hepatocellular carcinoma. Chinese Chemical Letters 2022; 33(7): 3371 doi: 10.1016/j.cclet.2022.03.079
|
| 12 |
Michal A. Rahat. Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.855978
|
| 13 |
Shiren Sun, Heng Li, Jianghua Chen, Qi Qian. Lactic Acid: No Longer an Inert and End-Product of Glycolysis. Physiology 2017; 32(6): 453 doi: 10.1152/physiol.00016.2017
|
| 14 |
Muhammed H. Elnaggar, Abdelrahman I. Abushouk, Ahmed H.E. Hassan, Hadeer M. Lamloum, Amira Benmelouka, Shurouk A. Moatamed, Hossam Abd-Elmegeed, Somia Attia, Aya Samir, Nouran Amr, Dina Johar, Samy Zaky. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. Seminars in Cancer Biology 2021; 69: 91 doi: 10.1016/j.semcancer.2019.08.016
|
| 15 |
Yufan Zhang, Jianjing Liu, Yunchuan Sun, Xiaozhou Yu, Jian Wang, Dong Dai, Yanjia Zhu, Xiuyu Song, Lei Zhu, Xiaofeng Li, Wengui Xu. Enhanced glucose metabolism mediated by CD147 is associated with 18F‐FDG PET/CT imaging in lung adenocarcinoma. Thoracic Cancer 2020; 11(5): 1245 doi: 10.1111/1759-7714.13383
|
| 16 |
Maria Cristina Oliveira, João D. G. Correia. Clinical application of radioiodinated antibodies: where are we?. Clinical and Translational Imaging 2022; 10(2): 123 doi: 10.1007/s40336-021-00477-2
|
| 17 |
Yuan Wang, Lin Yuan, Xiang-Min Yang, Ding Wei, Bin Wang, Xiu-Xuan Sun, Fei Feng, Gang Nan, Ye Wang, Zhi-Nan Chen, Huijie Bian. A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway. Clinical & Experimental Metastasis 2015; 32(1): 39 doi: 10.1007/s10585-014-9689-7
|
| 18 |
Hongtao Zhang. Will cancer cells be defeated by sodium bicarbonate?. Science China Life Sciences 2017; 60(3): 326 doi: 10.1007/s11427-016-0373-3
|
| 19 |
Wenzhe Fan, Yanqin Wu, Mingjian Lu, Wang Yao, Wei Cui, Yue Zhao, Yu Wang, Jiaping Li. A meta-analysis of the efficacy and safety of iodine [131I] metuximab infusion combined with TACE for treatment of hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2019; 43(4): 451 doi: 10.1016/j.clinre.2018.09.006
|
| 20 |
Tian Tian, Jian Ruan, Jia Zhang, Chun-Xia Zhao, Dong Chen, Jianzhen Shan. Nanocarrier-Based Tumor-Targeting Drug Delivery Systems for Hepatocellular Carcinoma Treatments: Enhanced Therapeutic Efficacy and Reduced Drug Toxicity. Journal of Biomedical Nanotechnology 2022; 18(3): 660 doi: 10.1166/jbn.2022.3297
|
| 21 |
Nicolò Brandi, Matteo Renzulli. The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(10): 8598 doi: 10.3390/ijms24108598
|
| 22 |
Ming Tang, Wen-Liang Li, Jia-Yu Li, Juan Lv, Fu-Kun Chen, Jia-Lun Zhu, Peng-Jie Liu. Analysis of factors influencing the distribution of 131-I in combined treatment of Licartin with transcatheter arterial chemoembolization in primary hepatic carcinoma. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.993948
|
| 23 |
Sagun Parakh, Sze Ting Lee, Hui K. Gan, Andrew M. Scott. Radiolabeled Antibodies for Cancer Imaging and Therapy. Cancers 2022; 14(6): 1454 doi: 10.3390/cancers14061454
|
| 24 |
Jiajun Ye, Weidong Yang, Zhaojuan Xie, Yuhao Yan, Guoquan Li, Guiyu Li, Xiang Li, Wenhui Ma, Fei Kang, Mingru Zhang, Jing Wang. Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with 131I-Labeling and SPECT Imaging. Molecular Pharmaceutics 2023; 20(3): 1750 doi: 10.1021/acs.molpharmaceut.2c00954
|